Datasheet
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Commission Regulation (EU)
2015/830
ChemaskĀ®
SECTION 11: Toxicological information
Potential chronic health effects
Potential acute health effects
Inhalation
:
Exposure to decomposition products may cause a health hazard. Serious effects
may be delayed following exposure.
Do not ingest. If swallowed then seek immediate medical assistance.
:
Ingestion
Skin contact
:
May cause sensitisation by skin contact.
May cause eye irritation.
:
Eye contact
Once sensitized, a severe allergic reaction may occur when subsequently exposed
to very low levels.
General
:
No known significant effects or critical hazards.
Carcinogenicity
:
No known significant effects or critical hazards.
Mutagenicity
:
No known significant effects or critical hazards.
Teratogenicity
:
Not available.
Conclusion/Summary
:
Not available.
Developmental effects
:
No known significant effects or critical hazards.
Fertility effects
:
No known significant effects or critical hazards.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation
Adverse symptoms may include the following:
headache
dizziness/vertigo
drowsiness/fatigue
Adverse symptoms may include the following:
Irritating to mouth, throat and stomach.
Ingestion Seek medical attention.
Adverse symptoms may include the following:
irritation
redness
:
:
:
Eye contact
:
Adverse symptoms may include the following:
irritation
redness
watering
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Short term exposure
Long term exposure
Potential immediate
effects
Potential delayed effects
:
:
Potential immediate
effects
Potential delayed effects
:
:
Other information
:
Not available.
Not available.
Not available.
Not available.
Not available.
12.1 Toxicity
SECTION 12: Ecological information
Date of issue/Date of revision
:
5/15/2017
Date of previous issue
:
No previous validation
Version
:
1
10/14










